Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,47 USD | +2,49% | +4,88% | -17,94% |
Omzet 2024 * | 4,45 mln. 4,1 mln. | Omzet 2025 * | 1,27 mln. 1,17 mln. | Marktkapitalisatie | 136 mln. 125 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -77 mln. -70,89 mln. | Nettowinst (verlies) 2025 * | -92 mln. -84,7 mln. | EV/omzet 2024 * | 2,08 x |
Nettoliquiditeiten 2024 * | 127 mln. 117 mln. | Nettoliquiditeiten 2025 * | 30,93 mln. 28,48 mln. | EV/omzet 2025 * | 82,8 x |
K/w-verhouding 2024 * |
-1,95
x | K/w-verhouding 2025 * |
-2,04
x | Werknemers | 94 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 92,08% |
Recentste transcriptie over Omega Therapeutics, Inc.
1 dag | +2,49% | ||
1 week | +4,88% | ||
Lopende maand | +10,76% | ||
1 maand | +2,92% | ||
3 maanden | -36,50% | ||
6 maanden | +23,50% | ||
Lopend jaar | -17,94% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mahesh Karande
CEO | Chief Executive Officer | 51 | 01-06-19 |
Joshua Reed
DFI | Director of Finance/CFO | 51 | 23-05-22 |
Chief Tech/Sci/R&D Officer | - | 01-01-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Luke Beshar
BRD | Director/Board Member | 65 | 01-05-21 |
John Mendlein
BRD | Director/Board Member | 64 | 01-01-20 |
Christian Schade
CHM | Chairman | 63 | 10-07-23 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - | |
0.01% | 0 M€ | 0,00% | - | |
0.00% | 34 M€ | +4,49% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
20-05-24 | 2,47 | +2,49% | 404 794 |
17-05-24 | 2,41 | +1,26% | 272 038 |
16-05-24 | 2,38 | +4,39% | 195 264 |
15-05-24 | 2,28 | -3,39% | 414 185 |
14-05-24 | 2,36 | +0,21% | 426 960 |
uitgestelde koers Nasdaq, 20 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-17,94% | 136 mln. | |
+41,79% | 54,04 mld. | |
-0,56% | 41,92 mld. | |
+49,62% | 41,96 mld. | |
-7,20% | 28,35 mld. | |
+12,59% | 26,35 mld. | |
-21,51% | 19 mld. | |
+6,92% | 13 mld. | |
+24,91% | 12,19 mld. | |
+29,60% | 12,28 mld. |